Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Other Accumulated Expenses (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Other Accumulated Expenses of $27.53 million for Q3 2026, down 32.2% from $40.6 million a year earlier but up 48.9% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2025, Amneal Pharmaceuticals' Other Accumulated Expenses came in at $43.26 million, up 36.2% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 41.7% (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Other Accumulated Expenses was $31.76 million in FY2024 (-58.8%), $76.99 million in FY2023 (-28.4%), $107.48 million in FY2022 (+85.3%) and $58 million in FY2021 (+667.1%).
  • Quarterly Other Accumulated Expenses has run from a low of $10.55 million in Q1 2026 to a high of $275.34 million in Q2 2022 over five years.
  • On a year-over-year basis, Other Accumulated Expenses has declined in each of the last three quarters, with an average decline of 9.0% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2021, with growth of 667.1%; the weakest was Q1 2026, with a decline of 75.7%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $18.49 million (Q2 2026), $10.55 million (Q1 2026) and $43.26 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 27.53 Mn
Jun 30, 2026 18.49 Mn
Mar 31, 2026 10.55 Mn
Dec 31, 2025 43.26 Mn
Sep 30, 2025 40.60 Mn
Jun 30, 2025 41.52 Mn
Mar 31, 2025 43.50 Mn
Dec 31, 2024 31.76 Mn
Sep 30, 2024 30.18 Mn
Jun 30, 2024 30.74 Mn
Mar 31, 2024 30.13 Mn
Dec 31, 2023 76.99 Mn
Sep 30, 2023 76.83 Mn
Jun 30, 2023 77.01 Mn
Mar 31, 2023 76.32 Mn
Dec 31, 2022 107.48 Mn
Sep 30, 2022 176.09 Mn
Jun 30, 2022 275.34 Mn
Mar 31, 2022 15.96 Mn
Dec 31, 2021 58.00 Mn
API Access

Amneal Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AMRX&period=max&api_key=YOUR_API_KEY